This brand name is authorized in Poland
The drug HIPURAN contains one active pharmaceutical ingredient (API):
1
Sodium iodohippurate ¹³¹I
UNII 9BRV734R3E - IODOHIPPURATE SODIUM I-131
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
V09CX02 | Sodium iodohippurate (131I) | V Various → V09 Diagnostic radiopharmaceuticals → V09C Renal system → V09CX Other renal system diagnostic radiopharmaceuticals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100048720 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.